Owner Scorecard


The groupings / Health Care / Life Sciences Tools & Services

A grouping · a comparative table

Life Sciences Tools & Services

41 companies across the library’s three pools, one row each. The columns are the line items this kind of business is read on; each header names its basis, and the margins and returns are medians over each company’s readable record — the through-cycle level, never one year’s print. Rows open largest first by latest-year revenue, and every column sorts both ways — the re-ordering is the reader’s own act, and a sorted view keeps its order in the address bar. The company stays in view as the columns scroll. A dash is a figure that could not be read; n/a is one that does not apply to that member; both sit at the back of a sorted column.

As a group: median revenue $982M; median gross margin 53.5%; median operating margin -8.5%; median owner earnings $88M; median return on invested capital -1.1%; 19 of 41 hold net cash. Medians of this table’s own columns, over the members each applies to · data as of August 17, 2026.

Pick two to four to weigh side by side. Compare these →
latest fiscal year, USD median over the record median over the record op. cash − maintenance capex · latest FY, USD after tax · median over the record debt − cash & ST investments · latest FY, USD
IQV IQVIA Holdings Inc. Life Sciences Tools & Services $16.3B9.2%$2.1B5.5%$13.6B
LH Labcorp Life Sciences Tools & Services $14.0B28.5%11.9%$1.2B7.9%$5.6B
DGX Quest Diagnostics Life Sciences Tools & Services $11.0B34.7%14.6%$1.4B10.4%$5.3B
ICLR ICON plc Life Sciences Tools & Services $8.3B29.2%13.3%$884M16.5%$1.2B
A Agilent Technologies Inc. Life Sciences Tools & Services $6.9B53.8%19.1%$1.3B17.1%$1.3B
AVTR Avantor Inc. Life Sciences Tools & Services $6.6B33.6%10.0%$495M6.8%$3.6B
INCY Incyte Life Sciences Tools & Services $5.1B94.7%15.0%24.4%$16.7B
ILMN Illumina Inc. Life Sciences Tools & Services $4.3B67.2%18.2%$931M16.4%+$143M cash
MTD Mettler-Toledo International Inc. Life Sciences Tools & Services $4.0B58.4%26.1%$905M43.3%$2.1B
CRL Charles River Labs Life Sciences Tools & Services $4.0B84.0% · 2y14.7%$518M9.0%$1.9B
BRKR Bruker Life Sciences Tools & Services $3.4B47.8%13.2%$43M17.7%$1.6B
EXAS Exact Sciences Life Sciences Tools & Services $3.2B70.5%-36.6%$357M-13.1%$1.4B
WAT Waters Corporation Life Sciences Tools & Services $3.2B58.9%28.8%$564M28.2%$820M
ULS UL Solutions Inc. Life Sciences Tools & Services $3.1B48.2%16.2%$403M27.0%$196M
RVTY Revvity Inc. Life Sciences Tools & Services $2.9B48.4%12.8%$509M4.1%$2.3B
FTRE Fortrea Holdings Inc. Life Sciences Tools & Services $2.7B1.1%$88M0.8%$878M
BIO Bio-Rad Life Sciences Tools & Services $2.6B54.7%10.2%$375M3.0%+$331M cash
MEDP Medpace Holdings Life Sciences Tools & Services $2.5B17.6%$682M27.3%+$497M cash
NTRA Natera Inc. Life Sciences Tools & Services $2.3B36.7% · 3y-46.0%$174M-62.2%+$793M cash
RDNT RadNet Life Sciences Tools & Services $2.0B12.6% · 4y4.9%$147M4.0%$323M
GH Guardant Health Inc. Life Sciences Tools & Services $982M60.8% · 3y-101.3%($233M)-29.6%$1.1B
CAI Caris Life Sciences Inc. Life Sciences Tools & Services $812M-62.4%$67M+$420M cash
NEO NeoGenomics Inc. Life Sciences Tools & Services $727M42.4%-8.5%($22M)-7.1%$379M
TXG 10x Genomics Inc. Life Sciences Tools & Services $643M76.7%-31.9%$130M-42.0%+$474M cash
VCYT Veracyte Inc. Life Sciences Tools & Services $517M63.8%-24.0%$127M-11.5%+$363M cash
CDNA CareDx Inc. Life Sciences Tools & Services $380M60.6% · 4y-19.8%-25.9%+$143M cash
CSTL Castle Biosciences Inc. Life Sciences Tools & Services $344M80.7%-14.6%$28M-18.4%+$289M cash
FLGT Fulgent Genetics Inc. Life Sciences Tools & Services $323M55.5%-10.0%($124M)-2.9%+$48M cash
BLLN BillionToOne Inc. Life Sciences Tools & Services $305M53.0%-30.9%$18M+$439M cash
CTKB Cytek Biosciences Inc. Life Sciences Tools & Services $201M56.2%-5.7%($9M)-5.5%+$91M cash
PACB Pacific Biosciences of California Inc. Life Sciences Tools & Services $160M37.6%-146.8%($114M)-50.6%$617M
GRAL GRAIL Inc. Common Stock Life Sciences Tools & Services $147M-382.0% · 1y($300M)-47.3% · 2y+$250M cash
NRC NRC Health Life Sciences Tools & Services $137M29.3%$19M46.5%$72M
MDXH MDxHealth SA Life Sciences Tools & Services $108M51.9%-102.3%($3M)-104.3%$47M
BNR Burning Rock Biotech Limited Life Sciences Tools & Services $80M70.9%-86.6%($5M)-229.2%+$71M cash
PSNL Personalis Inc. Life Sciences Tools & Services $70M25.6%-80.7%($79M)-48.4%+$235M cash
MASS 908 Devices Inc. Life Sciences Tools & Services $56M53.2%-72.8%($25M)-76.0%+$97M cash
EYPT EyePoint Inc. Life Sciences Tools & Services $31M-240.6%($242M)-113.4%+$277M cash
OABI OmniAb Inc. Life Sciences Tools & Services $19M-203.2%($37M)-18.4%+$26M cash
ABSI Absci Corporation Life Sciences Tools & Services $3M-278.3% · 1y($94M)-56.1%+$140M cash
ONMD OneMedNet Corp Life Sciences Tools & Services $1M-34.1%-671.2%($8M)$915K

Every figure is recomputed from the company’s own SEC or EDINET filings, the same way as on its page; the columns name facts, weigh nothing, and form no rank. Foreign filers are stated in US dollars at the dated reference rate (as of 2026-08-20) so each money column sorts on one basis; their own pages keep the records as filed. A foreign filer whose conversion terms are missing shows its money as filed and sorts to the back of the column — never a guessed conversion. Ratios and margins are currency-free.